EU5-30386-55810
3 vaccinations
5 coded responses
26 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 462 / IN
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-05
Survey response — days 1–6 daily, dose 1MedDRA: Depression — Feeling: Good · Be unable to do your normal daily activitiesFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
- 2021-01-07
- 2021-01-16
- 2021-01-21
-
2021-01-23
Dose 2 — Pfizer-BioNTech
-
2021-01-23
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Depression — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-02-08
- 2021-02-20
- 2021-03-01
-
2021-03-06
Survey response — day 42, dose 2MedDRA: Arthralgia, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Hashimotos flare up/joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
-
2021-07-26
Survey response — 6 months, dose 2MedDRA: Polycystic ovaries — Feeling: GoodFree text: PCOSMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-09
Dose 3 — Pfizer-BioNTech
- 2022-01-23
- 2022-01-23
- 2022-03-10
- 2022-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Depression
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Depression
Systemic reaction (other): Bruising at injection site
Release 5 — day 42, dose 2
Symptoms: Hashimotos flare up/joint pain
Release 9 — 6 months, dose 2
Symptoms: PCOS
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Polycystic ovaries | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release